Your browser doesn't support javascript.
False Positive Results in SARS-CoV-2 Serological Tests for Samples From Patients With Chronic Inflammatory Diseases.
Kharlamova, Nastya; Dunn, Nicky; Bedri, Sahl K; Jerling, Svante; Almgren, Malin; Faustini, Francesca; Gunnarsson, Iva; Rönnelid, Johan; Pullerits, Rille; Gjertsson, Inger; Lundberg, Karin; Månberg, Anna; Pin, Elisa; Nilsson, Peter; Hober, Sophia; Fink, Katharina; Fogdell-Hahn, Anna.
  • Kharlamova N; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Dunn N; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Bedri SK; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Jerling S; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Almgren M; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Faustini F; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Gunnarsson I; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Rönnelid J; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Pullerits R; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
  • Gjertsson I; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Lundberg K; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Månberg A; Department of Medicine Solna, Division of Rheumatology, Karolinska Institutet and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.
  • Pin E; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Nilsson P; Department of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Hober S; Department of Clinical Immunology and Transfusion Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Fink K; Department of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Fogdell-Hahn A; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Front Immunol ; 12: 666114, 2021.
Article in English | MEDLINE | ID: covidwho-1236673
ABSTRACT
Patients with chronic inflammatory diseases are often treated with immunosuppressants and therefore are of particular concern during the SARS-CoV-2 pandemic. Serological tests will improve our understanding of the infection and immunity in this population, unless they tests give false positive results. The aim of this study was to evaluate the specificity of SARS-Cov-2 serological assays using samples from patients with chronic inflammatory diseases collected prior to April 2019, thus defined as negative. Samples from patients with multiple sclerosis (MS, n=10), rheumatoid arthritis (RA, n=47) with or without rheumatoid factor (RF) and/or anti-cyclic citrullinated peptide antibodies (anti-CCP2) and systemic lupus erythematosus (SLE, n=10) with or without RF, were analyzed for SARS-CoV-2 antibodies using 17 commercially available lateral flow assays (LFA), two ELISA kits and one in-house developed IgG multiplex bead-based assay. Six LFA and the in-house validated IgG assay correctly produced negative results for all samples. However, the majority of assays (n=13), gave false positive signal for samples from patients with RA and SLE. This was most notable in samples from RF positive RA patients. No false positive samples were detected in any assay using samples from patients with MS. Poor specificity of commercial serological assays could possibly be, at least partly, due to interfering antibodies in samples from patients with chronic inflammatory diseases. For these patients, the risk of false positivity should be considered when interpreting results of the SARS-CoV-2 serological assays.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.666114

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Autoimmune Diseases / COVID-19 Serological Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study Topics: Long Covid Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged / Young adult Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: Fimmu.2021.666114